Breast Cancer Australia
 

2016 ANZBCTG Awards


Media Release - 21/11/2016

Members and researchers involved in the clinical trials research program of the Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) have been recognised at the ANZBCTG’s Annual Scientific Meeting (ASM).

The ASM was a joint conference with the Clinical Oncology Society of Australia and attracted approximately 1,000 delegates to the Gold Coast Convention and Exhibition Centre from 15-17 November 2016. The theme of the joint conference was Partners in Progress in Breast Cancer Research and Care.

During the ASM, the following ANZBCTG Awards were presented which recognise members and researchers, and their contributions to the ANZBCTG’s research program:

  • The ANZBCTG Gold Medal – Adjunct Professor Linda Reaby AM was presented with the ANZBCTG Gold Medal, which recognises the contribution and achievements of a member of the ANZBCTG and their significant role in the development and conduct of breast cancer clinical trials in this region. This was the first time that a consumer was presented with the Gold Medal. For more than 20 years, Linda has been a tireless advocate in raising awareness of the importance of breast cancer research particularly clinical trials and for consumers to be involved in the scientific decision making process. Linda was the inaugural Chair of the ANZBCTG’s Consumer Advisory Panel.
  • The Alan Coates Award for Excellence in Clinical Trials Research – Professor John Simes was presented with The Alan Coates Award in recognition of a research career spanning nearly four decades. He has been a tireless advocate of the value of clinical trials and was an early advocate for making trials research part of routine clinical practice. John is the Director and one of the founders of the NHMRC Clinical Trials Centre in Sydney and was an ANZBCTG Board Director for approximately 13 years.
  • The Robert Sutherland Award for Excellence in Translational Research – The 2016 recipient of this award was Professor Sunil Lakhani, who is the Head of Discipline of Molecular and Cellular Pathology at the University of Queensland’s School of Medicine. He has made an outstanding contribution to all aspects of clinical academic work and a major international contribution to translational research. Sunil has made a significant contribution in the area of triple negative/basal like breast cancers and has received pilot funding from the ANZBCTG to develop a theranostic approach to the management of brain metastases.
  • The John Collins Fellow Medal and Travel Grant – The 2016 recipient of the John Collins Fellow Medal was Dr Melissa Edwards, a trainee registrar in general surgery from New Zealand, who is mid-way through the first year of a PhD on the effects of comorbidity on breast cancer care and outcomes in New Zealand. This award was established to encourage potential academic breast cancer surgeons and registrars to become involved in the ANZBCTG’s research program.
  • The ANZBCTG Study Coordinator Prize – This award acknowledges the significant contribution to breast cancer clinical trials research achieved by a Study Coordinator at one of our participating institutions. The 2016 recipient was Ms Amy Tang from Box Hill Hospital who has worked closely with our research department for a number of years across numerous trials such as SOFT and TEXT.
  • Avon Travel Grants – These grants, which are generously supported by Avon, provide support for Study Coordinators to attend the ANZBCTG’s ASM. The 2016 recipients were: Mrs Diane Canning, Ms Alison Coote, Ms Louise Francisco, Mrs Jenny Gilchrist, Mrs Lauren Keller and Mrs Mona Martyn-Smith.

The ANZBCTG’s 2017 ASM will be held in Melbourne from 25-28 July 2017 at The Langham Hotel.

For almost 40 years, the ANZBCTG has conducted a national clinical trials research program for the treatment, prevention and cure of breast cancer. The ANZBCTG’s research program involves multicentre clinical trials, with 86 institutions and over 700 researchers throughout Australia and New Zealand. More than 14,000 women have participated in ANZBCTG breast cancer clinical trials. The fundraising department of the ANZBCTG is the Breast Cancer Institute of Australia (BCIA). For more information about the ANZBCTG, visit the website www.anzbctg.org.


Media contact: Anna Fitzgerald, ANZBCTG Communications Manager
Phone:  02 4925 5255 or 0400 304 224 or Email:  anna.fitzgerald@anzbctg.org